OrthoPediatrics (NASDAQ:KIDS) Downgraded to “Sell” Rating by Wall Street Zen

Wall Street Zen lowered shares of OrthoPediatrics (NASDAQ:KIDS) from a hold rating to a sell rating in a research report report published on Saturday.

Several other equities analysts also recently weighed in on KIDS. Needham & Company LLC dropped their target price on OrthoPediatrics from $42.00 to $26.00 and set a “buy” rating for the company in a research report on Wednesday, October 29th. BTIG Research restated a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a report on Wednesday, October 29th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. TD Cowen upgraded shares of OrthoPediatrics to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target for the company. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $23.89.

OrthoPediatrics Trading Down 0.5%

KIDS opened at $16.96 on Friday. OrthoPediatrics has a 52 week low of $15.28 and a 52 week high of $26.40. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28. The business has a fifty day simple moving average of $17.67 and a 200-day simple moving average of $18.20. The firm has a market cap of $425.36 million, a P/E ratio of -8.70 and a beta of 1.12.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC raised its holdings in shares of OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after purchasing an additional 452,840 shares in the last quarter. Vanguard Group Inc. increased its holdings in OrthoPediatrics by 1.1% in the third quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock valued at $17,813,000 after buying an additional 10,927 shares during the last quarter. Marshall Wace LLP raised its stake in OrthoPediatrics by 6.0% in the third quarter. Marshall Wace LLP now owns 444,320 shares of the company’s stock valued at $8,233,000 after buying an additional 25,191 shares in the last quarter. Prosight Management LP lifted its holdings in OrthoPediatrics by 319.2% during the 3rd quarter. Prosight Management LP now owns 308,707 shares of the company’s stock worth $5,720,000 after buying an additional 235,060 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of OrthoPediatrics by 112.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock worth $4,937,000 after acquiring an additional 106,041 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.